Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 23873933
Maaty WS, et al. (2013) Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils. J Biol Chem 288, 27042-58 23873933
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T325-p - FPR1 (human)
Modsite: ASLERALtEDstQts SwissProt Entrez-Gene
Orthologous residues
FPR1 (human): T325‑p, FPR1 (mouse): T336‑p, FPR1 (rat): S329‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, western blotting
Relevant cell lines - cell types - tissues:  neutrophil-blood
Cellular systems studied:  primary cells
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
fMLP decrease
cytochalasin_B fMLP decrease

S328-p - FPR1 (human)
Modsite: ERALtEDstQtsDtA SwissProt Entrez-Gene
Orthologous residues
FPR1 (human): S328‑p, FPR1 (mouse): S339‑p, FPR1 (rat): S332‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, western blotting
Relevant cell lines - cell types - tissues:  neutrophil-blood
Cellular systems studied:  primary cells
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
fMLP decrease
cytochalasin_B fMLP decrease

T329-p - FPR1 (human)
Modsite: RALtEDstQtsDtAt SwissProt Entrez-Gene
Orthologous residues
FPR1 (human): T329‑p, FPR1 (mouse): A340‑p, FPR1 (rat): A333‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, western blotting
Relevant cell lines - cell types - tissues:  neutrophil-blood
Cellular systems studied:  primary cells
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
fMLP decrease
cytochalasin_B fMLP decrease

T331-p - FPR1 (human)
Modsite: LtEDstQtsDtAtNs SwissProt Entrez-Gene
Orthologous residues
FPR1 (human): T331‑p, FPR1 (mouse): T342‑p, FPR1 (rat): T335‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, western blotting
Relevant cell lines - cell types - tissues:  neutrophil-blood
Cellular systems studied:  primary cells
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
fMLP decrease
cytochalasin_B fMLP decrease

S332-p - FPR1 (human)
Modsite: tEDstQtsDtAtNst SwissProt Entrez-Gene
Orthologous residues
FPR1 (human): S332‑p, FPR1 (mouse): S343‑p, FPR1 (rat): S336‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, western blotting
Relevant cell lines - cell types - tissues:  neutrophil-blood
Cellular systems studied:  primary cells
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
fMLP decrease
cytochalasin_B fMLP decrease

T334-p - FPR1 (human)
Modsite: DstQtsDtAtNstLP SwissProt Entrez-Gene
Orthologous residues
FPR1 (human): T334‑p, FPR1 (mouse): T345‑p, FPR1 (rat): T338‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, western blotting
Relevant cell lines - cell types - tissues:  neutrophil-blood
Cellular systems studied:  primary cells
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
fMLP decrease
cytochalasin_B fMLP decrease

T336-p - FPR1 (human)
Modsite: tQtsDtAtNstLPsA SwissProt Entrez-Gene
Orthologous residues
FPR1 (human): T336‑p, FPR1 (mouse): T347‑p, FPR1 (rat): T340‑p
Characterization
Methods used to characterize site in vivo mass spectrometry, western blotting
Relevant cell lines - cell types - tissues:  neutrophil-blood
Cellular systems studied:  primary cells
Species studied:  human
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
fMLP decrease
cytochalasin_B fMLP decrease